title: Isotopic synovectomy with P-32 in paediatric patients with haemophilia.
abstract: Isotopic synovectomy is being proposed as an option in the treatment of patients with haemophilic arthropathy. We present our experience with 11 paediatric patients who underwent 17, P-32 isotopic synovectomies for chronic haemophilic arthropathy. P-32 was injected into the joint per protocol, approved by the institutional review board. All our patients were male. Nine were factor VIII and two were factor IX deficient. The following joints were treated: ankle (n=10 procedures), elbow (n=5) and knee (n=2). The first procedure was performed on December 1993. None were human immunodeficiency virus positive. Mean age at the first procedure was 10.8 years (range, 5.2-15.2 years). Mean pretreatment joint clinical scores using the World Federation of Hemophilia guidelines for the ankle was 5.5 (SD +/- 2.3), the elbow 4.2 (+/-2.5), and knee 5.5 (+/-3.5); the corresponding post-treatment scores were 2.6 (+/-2.0), 1.4 (+/-0.5) and 2.5 (+/-3.5) respectively. Presynovectomy mean radiological scores using the Pettersson method were: ankle 1.8, elbow 1.8, and knee 1.5. A scoring system used in our centre for evaluating joints using magnetic resonance imaging (MRI) gave the following mean pretreatment scores: ankle 9.5, elbow 8.4, and knee 5.0. A marked decrease (an 80-100% decrease) in bleeding was seen in 13 of 17 procedures, and a moderate decrease (51-79% decrease) in two procedures, accounting for 85% reduction in bleeding into the target joints. The procedure was well tolerated and no untoward side-effects were noted as of May 1999, with a median follow-up of 40 months (range 19-65 months). None had any clinical evidence of cancer. Three patients had their joints retreated [elbow (one), ankle (two)]. These procedures were also well tolerated. In conclusion, in our study, isotopic synovectomy using P-32 appears to be feasible, safe and efficacious in the treatment of haemophilic arthropathy in paediatric patients who have been followed for a median of 40 months. As previously shown, MRI appears to give more detailed information about joint arthropathy than plain radiographs.
authors.affiliation: Department of Pediatrics, Medical College of Ohio Hospital, Toledo, Ohio, USA. pmathew@salud.unm.edu
authors.forename: P
authors.initials: P
authors.lastname: Mathew
authors.forename: D C
authors.initials: DC
authors.lastname: Talbut
authors.forename: A
authors.initials: A
authors.lastname: Frogameni
authors.forename: D
authors.initials: D
authors.lastname: Singer
authors.forename: M
authors.initials: M
authors.lastname: Chrissos
authors.forename: S
authors.initials: S
authors.lastname: Khuder
authors.forename: S
authors.initials: S
authors.lastname: Ohler
authors.forename: D
authors.initials: D
authors.lastname: Farley
authors.forename: C
authors.initials: C
authors.lastname: Michael
authors.forename: M G
authors.initials: MG
authors.lastname: Robinson
mesh_terms: D000293:Adolescent; D002648:Child; D002675:Child, Preschool; D005069:Evaluation Studies as Topic; D006395:Hemarthrosis / Q000000981:diagnostic imaging / Q000532:radiotherapy / Q000601:surgery; D006467:Hemophilia A / Q000150:complications* / Q000532:radiotherapy / Q000601:surgery; D002836:Hemophilia B / Q000150:complications / Q000000981:diagnostic imaging / Q000601:surgery; D006801:Humans; D007270:Injections, Intra-Articular / Q000009:adverse effects / Q000379:methods / Q000592:standards; D008279:Magnetic Resonance Imaging; D008297:Male; D010761:Phosphorus Radioisotopes / Q000627:therapeutic use*; D011859:Radiography; D000074402:Synovectomy; D013583:Synovial Membrane / Q000000981:diagnostic imaging / Q000528:radiation effects*; D016896:Treatment Outcome
chemical_list: D010761:Phosphorus Radioisotopes